TIVC Stock Analysis: Buy, Sell, or Hold?
TIVC - Tivic Health Systems, Inc. Common Stock
$1.40
0.07 (5.26%)
▲
5d:
+23.89%
30d:
+41.59%
90d:
+17.15%
WAIT
LOW Confidence
Analysis Updated: Apr 27, 2026 12:00 AM ET
Earnings: May 21, 2026
11d
Get Alerted When TIVC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TIVC is 15.7% above its trading range ($1.21). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TIVC is 15.7% above its trading range ($1.21). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TIVC is currently trading at $1.40, which is considered extended relative to its 30-day fair value range of $0.93 to $1.21.
Technical Outlook: Technically, TIVC is in a downtrend. The price is approaching resistance at $1.39. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: TIVC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $210.00 (+14900.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TIVC is in a downtrend. The price is approaching resistance at $1.39. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: TIVC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $210.00 (+14900.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.93 -
$1.21
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+15.7% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 14900.0% below Wall St target ($210.00)
- WARNING: Recommendation downgraded due to 15.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.93 -
$1.21
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.89
Resistance Level
$1.39
Current Trend
Downtrend
Technical data as of
Apr 27, 2026
Fundamental Context
Wall Street Target
$210.00
(+14900.0%)
Revenue Growth (YoY)
15.9%
Share & Embed Analysis
Last updated: May 09, 2026 8:44 AM ET
Data refreshes hourly during market hours. Next update: 9:44 AM
Data refreshes hourly during market hours. Next update: 9:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TIVC showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Sheryle Bolton
BUY
10000 shares
2026-04-15
Christina Rizopoulos Val…
BUY
19000 shares
2026-04-01
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$394 | 53 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$326 | 58 HOLD |
